Skip to main content

Table 1 The inclusion and exclusion criteria

From: Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty

Inclusion criteria

Exclusion criteria

1. Receiving unilateral primary TKA due to end-stage knee diseases

1. UKA

2. Receiving pre- and intraoperative TXA or pre-, intra-, and postoperative TXA

2. Bilateral TKA

3. Preoperative hemoglobin level > 90 g/L

3. Tumor-related TKA

 

4. Revision TKA

 

5. Combined with significant hepatic or renal dysfunction

 

6. Combined with coagulation dysfunction preoperatively

 

7. Combined with knee infection preoperatively

  1. TKA total knee arthroplasty, TXA tranexamic acid, UKA unilateral knee arthroplasty